INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL (PSCI)

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / S&P SMLCP INDL
Number of holders
30
Total 13F shares, excl. options
482K
Shares change
+21.1K
Total reported value, excl. options
$32.1M
Value change
+$1.5M
Number of buys
6
Number of sells
-18
Price
$66.63

Significant Holders of INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL (PSCI) as of Q2 2019

37 filings reported holding PSCI - INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL as of Q2 2019.
INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL (PSCI) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 482K shares .
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (125K shares), Kovitz Investment Group Partners, LLC (56.1K shares), CITADEL ADVISORS LLC (37.2K shares), WELLS FARGO & COMPANY/MN (35.4K shares), SALEM INVESTMENT COUNSELORS INC (34.5K shares), MORGAN STANLEY (24K shares), UBS Group AG (23.6K shares), ROYAL BANK OF CANADA (21.4K shares), AMERIPRISE FINANCIAL INC (20.4K shares), and GOLDMAN SACHS GROUP INC (19.7K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.